1. Home
  2. MGNX vs BLZE Comparison

MGNX vs BLZE Comparison

Compare MGNX & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGNX
  • BLZE
  • Stock Information
  • Founded
  • MGNX 2000
  • BLZE 2007
  • Country
  • MGNX United States
  • BLZE United States
  • Employees
  • MGNX N/A
  • BLZE N/A
  • Industry
  • MGNX Biotechnology: Pharmaceutical Preparations
  • BLZE Computer Software: Prepackaged Software
  • Sector
  • MGNX Health Care
  • BLZE Technology
  • Exchange
  • MGNX Nasdaq
  • BLZE Nasdaq
  • Market Cap
  • MGNX 257.3M
  • BLZE 281.3M
  • IPO Year
  • MGNX 2013
  • BLZE 2021
  • Fundamental
  • Price
  • MGNX $3.24
  • BLZE $6.25
  • Analyst Decision
  • MGNX Buy
  • BLZE Strong Buy
  • Analyst Count
  • MGNX 11
  • BLZE 4
  • Target Price
  • MGNX $8.57
  • BLZE $11.50
  • AVG Volume (30 Days)
  • MGNX 770.4K
  • BLZE 500.0K
  • Earning Date
  • MGNX 11-05-2024
  • BLZE 11-07-2024
  • Dividend Yield
  • MGNX N/A
  • BLZE N/A
  • EPS Growth
  • MGNX N/A
  • BLZE N/A
  • EPS
  • MGNX N/A
  • BLZE N/A
  • Revenue
  • MGNX $141,329,000.00
  • BLZE $122,579,000.00
  • Revenue This Year
  • MGNX $119.63
  • BLZE $27.44
  • Revenue Next Year
  • MGNX N/A
  • BLZE $16.01
  • P/E Ratio
  • MGNX N/A
  • BLZE N/A
  • Revenue Growth
  • MGNX 16.68
  • BLZE 27.41
  • 52 Week Low
  • MGNX $2.95
  • BLZE $4.91
  • 52 Week High
  • MGNX $21.88
  • BLZE $12.65
  • Technical
  • Relative Strength Index (RSI)
  • MGNX 37.79
  • BLZE 42.23
  • Support Level
  • MGNX $3.61
  • BLZE $5.50
  • Resistance Level
  • MGNX $5.10
  • BLZE $6.74
  • Average True Range (ATR)
  • MGNX 0.35
  • BLZE 0.49
  • MACD
  • MGNX -0.10
  • BLZE -0.15
  • Stochastic Oscillator
  • MGNX 4.62
  • BLZE 29.07

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 x CTLA-4), Tebotelimab (PD-1 x LAG-3), MGD024 (CD123 x CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV x CD3).

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and other regions.

Share on Social Networks: